Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer

Scandinavian Journal of Urology

Volumn 48, Issue 3, 2014, Pages 276-283

  Jancke, Georg ^a   Rosell, Johan ^b   Jahnson, Staffan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Bladder cancer; Progression; Recurrence; Resident; Specialist; Surgical experience; TURB

Indexed keywords

BCG VACCINE; CYTOSTATIC AGENT;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NON MUSCLE INVASIVE BLADDER CANCER; NORMAL HUMAN; PRIORITY JOURNAL; RESIDENT; SKILL; SURGEON; SURGICAL TRAINING; TRANSURETHRAL RESECTION OF BLADDER TUMOR; WORK EXPERIENCE; CANCER STAGING; CARCINOMA, TRANSITIONAL CELL; CLINICAL COMPETENCE; COHORT ANALYSIS; DISEASE COURSE; LEARNING CURVE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CLINICAL COMPETENCE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LEARNING CURVE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84900538510     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/21681805.2013.864327     Document Type: Article

References (18)

1. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg 2007; 245: 777-83.
2. Joudi FN, Konety BR. The volume/outcome relationship in urologic cancer surgery. Support Cancer Ther 2004; 2: 42-6.
3. Goossens-Laan CA, Gooiker GA, van Gijn W, Post PN, Bosch JLHR, Kil PJM, et al. A systemic review and metaanalysis of the relationship between hospital/surgical volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011; 59: 775-83.
4. McCabe JE, Jibawi A, Jawle PM. Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomes. Postgrad Med J 2007; 83: 556-60.
5. Barocas DA, Mitchell R, Chang SS, Cookson MS. Impact of surgeon and hospital volume on outcomes of radical prostatectomy. Urol Oncol 2010; 28: 243-50.
6. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, et al. Variations among individual surgeons in the rate of positive margin radical prostatectomy specimens. J Urol 2003; 170: 2292-5.
7. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007; 99: 1171-7.
8. Parmar MKB, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors and follow-up policies in the treatment of superficial bladder cancer: report from the British medical research council subgroup on superficial bladder cancer (urological cancer working party). J Urol 1989; 142: 284-8.
9. Sauter G, Algaba F, Amin M, et al. Tumours of the urinary system: non-invasive urothelial neoplasias. In Eble JN, Sauter G, Epstein Jl, Sesterhenn I, editors. WHO classification of classification of tumours of the urinary system and male genital organs. Lyon: IARCC Press; 2004. p 29-34.
10. Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first transurethral resection of bladder tumour (TURBT) specimen is a surrogate marker of resection quality and is dependent on operator experience. Eur Urol Suppl 2008; 7: 299.
11. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187.
12. Brausi M, Collete L, Kurth K, van der Meijden AP, OosterlinkW, Witjes JA, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523-31.
13. Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli TA. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 433-7.
14. Pode D, Alon Y, Horowitz AT, Vlodavsky I, Biran S. The mechanism of human bladder tumour implantation in an in vitro model. J Urol 1986; 136: 482-6.
15. Brausi MA, Gavioli M, Peracchia G, Viola M, Gilberto GL, Simonini G, et al. Dedicated teaching programs can improve the quality of TUR of non-muscle-invasive bladder tumours (NMIBT): experience of a single institution. Eur Urol Suppl 2008; 7: 180.
16. Nieder AM, Manoharan M. The role of the surgeon and transurethral resection in the treatment of superficial bladder cancer. TSW Urol 2006; 1: 24-9.
17. Adiyat KT, Katkoori D, Soloway CT, De Los Santos R, Manoharan M, Soloway MS. "Complete transurethral resection of the bladder tumour": are the guidelines being followed? J Urol 2010; 75: 365-7.
18. Sylvester RJ, Oosterlinck W, van der Meijden APM. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004; 171: 2186-90.